Impcl Divestment
Govt gets multiple expressions of interest for strategic sale of IMPCL
The government has received multiple expressions of interest for strategic sale of Indian Medicines Pharmaceutical Corporation Limited (IMPCL). "Multiple Expressions of Interest (EoIs) received for the strategic disinvestment of Indian Medicines Pharmaceutical Corporation Limited (IMPCL). The transaction will now move to the second stage," DIPAM Secretary Tuhin Kanta Pandey posted on X (formerly Twitter). The second stage would involve due diligence and subsequent issue of RFPs (request for proposals) for financial bids. The Department of Investment and Public Asset Management (DIPAM) had on August 31 invited EoIs from interested bidders for disinvestment of IMPCL. The last date for putting in preliminary bids was October 30. The government of India holds a 98.11 per cent stake in IMPCL, under the administrative control of the Ministry of Ayush. The remaining 1.89 per cent is held by Kumaon Mandal Vikas Nigam Ltd (KMVNL), an undertaking of the Uttarakhand government. KMVNL also ..
 "Govt gets multiple expressions of interest for strategic sale of IMPCL")
Govt invites Expression of Interest from bidders for IMPCL strategic sale
The turnover of the company rose by 59 per cent to Rs 261 crore in FY22. Its profit after tax stood at Rs 34 crore for 2021-22
 "Govt invites Expression of Interest from bidders for IMPCL strategic sale")
Govt invites Expression of Interest from bidders for IMPCL strategic sale
The government on Thursday invited Expression of Interest (EoI) from bidders by October 15 for strategic sale of Indian Medicines Pharmaceutical Corporation Ltd (IMPCL). The Government of India holds a 98.11 per cent stake in IMPCL, under the administrative control of the Ministry of Ayush. The remaining 1.89 per cent is held by Kumaon Mandal Vikas Nigam Ltd (KMVNL), an undertaking of the Government of Uttarakhand. "The Government of India intends to disinvest its entire stake in IMPCL through strategic disinvestment with transfer of management control. The KMVNL ...has expressed its willingness to disinvest along with GoI," the Department of Investment and Public Asset Management (DIPAM) said. The company is presently manufacturing 656 classical ayurvedic, 332 unani and 71 proprietary ayurvedic medicines for a varied spectrum of diseases. It supplies ayurveda and unani medicines to all the states under the National Ayush Mission (NAM) and 6,000 centres of Jan Aushadhi Kendras. "T
Govt to sell entire stake in IMPCL, invites bids for asset valuer
Bidders would be required to submit their interest by January 15 to the ministry.
